# Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

> **NCT01297231** · — · WITHDRAWN · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT01297231
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2012-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01297231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01297231, "Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01297231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
